Analysis of platelet-derived growth factor receptor A and oligodendrocyte transcription factor 2 markers following Hydroxychloroquine administration in animal induced multiple sclerosis model

Analysis of platelet-derived growth factor receptor A and oligodendrocyte transcription factor 2 markers following Hydroxychloroquine administration in animal induced multiple sclerosis model
It has been proven that following demyelination, Oligodendrocyte Progenitor Cells (OPCs) migrate to the lesion website and start to proliferate, and differentiate. This examine aimed to analyze the results of Hydroxychloroquine (HCQ) on the expression of OLIG-2 and PDGFR-α markers in the course of the myelination course of.
C57BL/6 mice had been fed cuprizone pellets for five weeks to induce demyelination and return to a standard weight-reduction plan for 1 week to stimulate remyelination. In the course of the Part I all the animals besides CPZ and Automobile teams had been uncovered to HCQ (2.5, 10, and 100 mg/kg) by way of consuming water.
On the finish of the examine, animals had been euthanized, perfused and the mind samples had been assessed for myelination and immunohistochemistry analysis. What’s exceptional is the excessive fee of Olig2 + cells within the teams handled with 10 and 100 mg/kg HCQ within the demyelination section and its lowering pattern within the remyelination section.
Nevertheless, there was no important distinction between teams throughout section I and Part II based mostly on the share of olig-2+/whole cells within the corpus callosum area. The variety of PDGFR-α+ cells within the group handled with 10 mg/kg HCQ was important within the first section (p worth < 0.05).
Contemplating that the 100 mg/kg HCQ group had the best degree of PDGFR-α in addition to the best degree of myelin restore in LFB staining, it might be inferred that it was the best dose in inducing proliferation and migration of OPCs.
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
ELISA-1
Beta2-Microglobulin ELISA kit ELISA Kit
LF-EK60047
Chicken thrombomodulin,TM ELISA KIT ELISA
QY-E80092

Bee Venom-Derived BBB Shuttle and its Correlation with Oligodendrocyte Proliferation Markers in Mice Mannequin of A number of Sclerosis

A number of sclerosis is a power demyelinating illness with a useful disturbance within the immune system and axonal damages. It was proven that Apamin as a blood-brain barrier shuttle acts as a Ca2+ activated Ok+ channels (SK channels) blocker.
On this examine, the results of Apamin on oligodendrocyte differentiation markers had been evaluated on an induced mannequin of MS. Briefly, C57BL/6 male mice (22 ± 5 g) besides the management group had been fed with 0.2% (w/w) cuprizone pellets for six weeks.
After cuprizone withdrawal, mice had been divided randomly into six teams. Apamin (100 µg/kg/BW) was administered intraperitoneally as a co-treatment throughout section I (demyelination) or post-treatment section II (remyelination) twice every week.
Mice had been anesthetized, perfused with phosphate-buffered saline, then fastened brains had been coronally sectioned and the modifications in oligodendrocytes markers reminiscent of Olig2, PDGFR-α, and BrdU incorporation had been assessed by immunohistochemistry assay.
Apamin administration elevated Olig2+ cells in section I as in comparison with the management group (p < 0.0001). Additionally, a lowering pattern in PDGFRa+ cells noticed after cuprizone withdrawal (p < 0.001). 5-Bromo-2′-deoxyuridine (BrdU) incorporation check was confirmed stimulation of oligodendrocyte progenitor cell proliferation in section I within the Apamin uncovered group (p < 0.0001), particularly on the subventricular zone.
This examine highlights the potential therapeutic results of Apamin as a bee venom-derived peptide on oligodendrocyte precursor proliferation and elevation in myelin content material in an oxidative induced a number of sclerosis mannequin because of cuprizone publicity.
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
ELISA-1 Alpha Diagnostics
Beta2-Microglobulin ELISA kit ELISA Kit
LF-EK60047 Abfrontier
Chicken thrombomodulin,TM ELISA KIT ELISA
QY-E80092 Qayee Biotechnology
Oxycodone ELISA
EK7130 BosterBio
Amphiphysin ELISA
LF-EK0189 Abfrontier

Oligodendrocyte Lineage Marker Expression in eGFP-GFAP Transgenic Mice

Oligodendrocytes, the myelinating cells of the central nervous system, orchestrate a number of key mobile capabilities within the mind and spinal twine, together with axon insulation, power switch to neurons, and, ultimately, modulation of immune responses.
There’s rising curiosity for acquiring dependable markers that may particularly label oligodendroglia and their progeny. In lots of research, anti-CC1 antibodies, presumably recognizing the protein adenomatous polyposis coli (APC), are used to label mature, myelinating oligodendrocytes.
Nevertheless, it has been mentioned whether or not anti-CC1 antibodies might acknowledge as effectively, underneath pathological situations, different cell populations, notably astrocytes. On this examine, we used transgenic mice by which astrocytes are labeled by the improved inexperienced fluorescent protein (eGFP) underneath the management of the human glial fibrillary acidic protein (GFAP) promoter.
By detailed co-localization research we had been capable of reveal that a important proportion of eGFP-expressing cells co-express markers of the oligodendrocyte lineage, such because the transcription issue Oligodendrocyte Transcription Issue 2 (OLIG2); the NG2 proteoglycan, also referred to as chrondroitin sulfate proteoglycan 4 (CSPG4); or APC.
The present discovering that the GFAP promoter drives transgene expression in cells of the oligodendrocyte lineage needs to be thought of when deciphering outcomes from co-localization research.
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
Alpha Diagnostics
Beta2-Microglobulin ELISA kit ELISA Kit
Abfrontier
Chicken thrombomodulin,TM ELISA KIT ELISA
Qayee Biotechnology

Bone marrow stromal cell transdifferentiation into oligodendrocyte-like cells utilizing triiodothyronine as a inducer with expression of platelet-derived development issue α as a maturity marker.

The current examine investigated the useful maturity of oligodendrocyte derived from rat bone marrow stromal cells (BMSC).
The BMSC had been remoted from feminine Sprague-Dawley rats and evaluated for various markers, reminiscent of fibronectin, CD106, CD90, Oct-Four and CD45.
Analysis of platelet-derived growth factor receptor A and oligodendrocyte transcription factor 2 markers following Hydroxychloroquine administration in animal induced multiple sclerosis model
Transdifferentiation of OLC from BMSC was obtained by exposing the BMSC to DMSO and 1 µM all-trans-retinoic acid in the course of the pre-induction stage after which induced by heregulin (HRG), platelet-derived development issue AA (PDGFR-alpha), fibroblast development issue and T3.
The neuroprogenitor cells (NPC) had been evaluated for nestin, neurofilament 68, neurofilament 160 and glial fibrillary acidic protein gene expression utilizing immunocytochemistry. The OLC had been assessed by immunocytochemistry for O4, oligo2, O1 and MBP marker and gene expression of PDGFR-alpha was examined by RT-PCR.
Our outcomes confirmed that the fibronectin, CD106, CD90, CD45 and Oct-Four had been expressed after the fourth passage. Additionally, the yield of OLC differentiation was about 71% when utilizing the O1, O4 and oligo2 markers.
Likewise, the expression of PDGFR-alpha in pre-oligodendrocytes was observed, whereas MBP expression was detected in oligodendrocyte after 6 days of the induction.
The conclusion of the examine confirmed that BMSC will be induced to transdifferentiate into mature OLC.
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
ELISA-1
Beta2-Microglobulin ELISA kit ELISA Kit
LF-EK60047
Chicken thrombomodulin,TM ELISA KIT ELISA
QY-E80092

Results of hexachlorophene on myelin marker enzymes in rat oligodendrocytes.

The antibacterial substance hexachlorophene (HCP) can have an effect on myelin formation or integrity resulting in intramyelinic oedema and vacuolation within the central nervous system by way of an unknown mechanism. These research had been performed to analyze the direct, dose-dependent results of HCP on myelin membrane markers in cultured oligodendrocytes (OLG) remoted from 4-7-day-old rat pups and cultured in vitro for as much as 5 wk.
2-wk-old OLG cultures had been uncovered to 0, 0.24 or 0.74 mum HCP for 48 hr. At 48 hr and once more at 5, 12 and 19 days after the top of dosing the myelin markers galactosylceramide (GalC), myelin fundamental protein (MBP), and a couple of’,3′-cyclic nucleotide 3′-phosphohydrolase (CNPase) had been quantified by ELISA or biochemical strategies.
DNA was measured to estimate whole cell mass and astrocyte contamination was decided by an ELISA process utilizing anti-glial fibrillary acidic protein (GFAP) as the first antibody. Due to the usage of a selective tradition medium, astrocyte contamination was initially low and continued to lower from wk 2 to Four as decided by GFAP binding.
CNPase, GalC and MBP ranges had been related in management and low-dose (0.24 mum HCP) cultures with a common improve in MBP and CNPase over time. Cultures uncovered to 0.74 mum HCP confirmed a decline in GalC proportional to decreased DNA content material with time, however ranges of MBP and CNPase elevated after dosing and had been at all times better than the corresponding ranges in management or low-dose cultures.

Myelin oligodendrocyte glycoprotein Antibody

49609-50ul 50ul
EUR 286.8

Myelin Oligodendrocyte Glycoprotein antibody

10R-7783 500 ug
EUR 664.8
Description: Mouse monoclonal Myelin Oligodendrocyte Glycoprotein antibody

anti-Myelin-oligodendrocyte glycoprotein

YF-PA13212 50 ug
EUR 435.6
Description: Mouse polyclonal to Myelin-oligodendrocyte glycoprotein

anti-Myelin-oligodendrocyte glycoprotein

YF-PA13213 100 ul
EUR 483.6
Description: Rabbit polyclonal to Myelin-oligodendrocyte glycoprotein

anti-Myelin-oligodendrocyte glycoprotein

YF-PA13214 100 ug
EUR 483.6
Description: Rabbit polyclonal to Myelin-oligodendrocyte glycoprotein

Myelin oligodendrocyte glycoprotein Rabbit mAb

A3992 20 μL
EUR 18

Myelin oligodendrocyte glycoprotein Rabbit mAb

A3992-100ul 100 ul
EUR 492

Myelin oligodendrocyte glycoprotein Rabbit mAb

A3992-200ul 200 ul
EUR 685.2

Myelin oligodendrocyte glycoprotein Rabbit mAb

A3992-20ul 20 ul
EUR 265.2

Myelin oligodendrocyte glycoprotein Rabbit mAb

A3992-50ul 50 ul
EUR 344.4

Myelin oligodendrocyte glycoprotein Conjugated Antibody

C49609 100ul
EUR 476.4

Recombinant Human Myelin Oligodendrocyte Glycoprotein

7-05617 10µg Ask for price

Recombinant Human Myelin Oligodendrocyte Glycoprotein

7-05618 50µg Ask for price

Recombinant Human Myelin Oligodendrocyte Glycoprotein

7-05619 1mg Ask for price

Myelin Oligodendrocyte Glycoprotein Recombinant Protein

91-041 0.05 mg
EUR 537.9
Description: Myelin Oligodendrocyte Glycoprotein (MOG) is a transmembrane protein, which is expressed exclusively in the CNS. MOG contains a single Ig-domain exposed to the extracellular space that allows autoantibodies easy access. MOG protein has been identified as a crucial autoantigen for multiple sclerosis in humans. MOG is capable to produce a demyelinating multiple sclerosis-like diseases in experimental animals, namely experimental autoimmune encephalomyelitis (EAE), in rodents and monkeys.

Myelin Oligodendrocyte Glycoprotein Recombinant Protein

91-511 0.05 mg
EUR 651.3
Description: Myelin Oligodendrocyte Glycoprotein (MOG) is a transmembrane protein, which is expressed exclusively in the CNS. MOG contains a single Ig-domain exposed to the extracellular space which allows autoantibodies easy access. MOG protein has been identified as a crucial autoantigen for multiple sclerosis in humans. MOG is capable to produce a demyelinating multiple sclerosis-like disease in experimental animals,namely experimental autoimmune encephalomyelitis (EAE) in rodents and monkeys.

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx104849
  • EUR 543.60
  • EUR 159.60
  • EUR 1545.60
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx103636
  • EUR 477.60
  • EUR 159.60
  • EUR 1328.40
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx103637
  • EUR 493.20
  • EUR 159.60
  • EUR 1362.00
  • EUR 661.20
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx103638
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx103639
  • EUR 560.40
  • EUR 159.60
  • EUR 1646.40
  • EUR 777.60
  • EUR 427.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx173648
  • EUR 376.80
  • EUR 944.40
  • EUR 493.20
  • EUR 184.80
  • EUR 309.60
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx173649
  • EUR 1011.60
  • EUR 526.80
  • 1 mg
  • 200 ug

Oligodendrocyte Myelin Glycoprotein (OMG) Antibody

20-abx133521
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx137143
  • EUR 560.40
  • EUR 777.60
  • 0.5 mg
  • 1 mg

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx113907
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Oligodendrocyte Myelin Glycoprotein (OMG) Antibody

20-abx006407
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

20-abx004094
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Oligodendrocyte Myelin Glycoprotein (OMG) Antibody

20-abx014682
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Oligodendrocyte Myelin Glycoprotein (OMG) Antibody

abx038191-100ug 100 ug
EUR 469.2

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

abx030041-400ul 400 ul
EUR 627.6

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

abx030041-80l 80 µl
EUR 343.2

Oligodendrocyte Myelin Glycoprotein (OMG) Antibody

20-abx211642
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul
These research counsel a direct, dose-related poisonous impact of HCP accompanied by a stimulation of MBP and CNPase however not of GalC manufacturing within the membranes of the recovering OLG following removing of HCP.
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
Alpha Diagnostics
Beta2-Microglobulin ELISA kit ELISA Kit
Abfrontier
Chicken thrombomodulin,TM ELISA KIT ELISA
Qayee Biotechnology
Oxycodone ELISA
BosterBio
Amphiphysin ELISA
Abfrontier

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

Activated CD4 + T cells and CD14 hi CD16 + monocytes correlate with antibody response following influenza virus infection in humans

Activated CD4 + T cells and CD14 hi CD16 + monocytes correlate with antibody response following influenza virus infection in humansActivated CD4 + T cells and CD14 hi CD16 + monocytes correlate with antibody response following influenza virus infection in humans

The failure to mount an antibody response following viral an infection or seroconversion failure is a largely underappreciated and poorly understood phenomenon. Right here, we recognized immunologic markers related to